#ThinkSabio Latest News
Announces New Long-Term Data from Phase 1/2 DELIVER Trial of DYNE-251 in DMD Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
Announces New Long-Term Data from Phase 1/2 DELIVER Trial of DYNE-251 in DMD Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
